CN115887584B - 一种降压中药代茶饮 - Google Patents
一种降压中药代茶饮 Download PDFInfo
- Publication number
- CN115887584B CN115887584B CN202211349577.4A CN202211349577A CN115887584B CN 115887584 B CN115887584 B CN 115887584B CN 202211349577 A CN202211349577 A CN 202211349577A CN 115887584 B CN115887584 B CN 115887584B
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- traditional chinese
- chinese medicine
- blood pressure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 38
- 230000036772 blood pressure Effects 0.000 title claims abstract description 27
- 241001122767 Theaceae Species 0.000 title description 16
- 241000185686 Apocynum venetum Species 0.000 claims abstract description 14
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 14
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 14
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 14
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 14
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 14
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 14
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 14
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 14
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 14
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 14
- 241000305491 Gastrodia elata Species 0.000 claims abstract description 14
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 14
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 14
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 14
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 12
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 12
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 12
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 12
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 5
- 244000269722 Thea sinensis Species 0.000 claims abstract 3
- 241000209020 Cornus Species 0.000 claims description 12
- 235000003805 Musa ABB Group Nutrition 0.000 claims description 11
- 240000008790 Musa x paradisiaca Species 0.000 claims description 11
- 235000015266 Plantago major Nutrition 0.000 claims description 11
- 230000003276 anti-hypertensive effect Effects 0.000 claims description 6
- 235000013361 beverage Nutrition 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 5
- 235000013305 food Nutrition 0.000 claims description 4
- 240000008042 Zea mays Species 0.000 claims description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 3
- 235000005822 corn Nutrition 0.000 claims description 3
- 239000002657 fibrous material Substances 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 235000013616 tea Nutrition 0.000 claims 2
- 241000759833 Cornus officinalis Species 0.000 claims 1
- 235000015092 herbal tea Nutrition 0.000 claims 1
- 235000019640 taste Nutrition 0.000 abstract description 13
- 210000000582 semen Anatomy 0.000 abstract description 3
- 240000006766 Cornus mas Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 21
- 210000004369 blood Anatomy 0.000 description 18
- 239000008280 blood Substances 0.000 description 18
- 210000004185 liver Anatomy 0.000 description 15
- 241001092040 Crataegus Species 0.000 description 9
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 208000002173 dizziness Diseases 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 230000001914 calming effect Effects 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 206010020772 Hypertension Diseases 0.000 description 5
- 235000003143 Panax notoginseng Nutrition 0.000 description 5
- 241000180649 Panax notoginseng Species 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 208000031226 Hyperlipidaemia Diseases 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 208000019901 Anxiety disease Diseases 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 230000036506 anxiety Effects 0.000 description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000035487 diastolic blood pressure Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010005746 Blood pressure fluctuation Diseases 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 108090000932 Calcitonin Gene-Related Peptide Proteins 0.000 description 1
- 102000004414 Calcitonin Gene-Related Peptide Human genes 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108050009340 Endothelin Proteins 0.000 description 1
- 102000002045 Endothelin Human genes 0.000 description 1
- 208000007530 Essential hypertension Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 206010041235 Snoring Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002892 effect on hypertension Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000001434 glomerular Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 208000027906 leg weakness Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229940118019 malondialdehyde Drugs 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
本发明公开一种降压中药代茶饮,其由罗布麻、山楂、山萸肉、三七花、枸杞子、车前子、天麻制成,本发明全方寒热并用,消补兼施,共奏清热平肝、化痰降浊、培元固本之功,能调和气血,平衡阴阳,从不同层面具有多靶点降压作用,兼具调节血脂、血糖控制功效,且可改善冠脉血流、提高心肌细胞缺氧耐受性、中枢神经系统调节、体液代谢、心脑肾等器官的灌注等病症。并且本发明注重口感的选择配伍,使得患者能够理解并接受,利于患者长期饮用。
Description
技术领域
本发明涉及中药饮品技术领域,尤其涉及一种降压中药代茶饮。
背景技术
中医认为原发性高血压系肝脾肾多脏功能失衡,阴阳平衡被打破,造成气机升降出入失司,精血不能濡养脏器、清窍、肢体,机体呈现出上部有热、中焦痰浊瘀堵、下元虚衰的状态,其病机复杂,体虚同时可见痰、湿、热、瘀、寒、凝、虚、气滞互相勾结,虚实夹杂,寒热错杂,临床常见症状为头晕、头胀、头痛,眼睛发胀,口苦口干,失眠,焦虑,抑郁,肥胖,腹胀,打鼾,痰多,疲劳乏力,腰酸,腿软,多伴有高脂血症、高尿酸血症等,严重者会导致外周动脉粥样硬化、脑供血不足、甚至心肌缺血、眼底动脉硬化、肾小球动脉硬化等靶器官受损。研究表明防控高血压可以有效降低心血管疾病的发病率和死亡率。
在高血压病的治疗过程中,化学药虽然作用迅速,但降压过程中血压波动大,副作用也大,可明显影响水,电解质,血脂,血糖等的代谢;直接损伤心、脑、肾等器官,同时这些药物对高血脂,高血粘、血管硬化,靶器官的损伤等无改善作用。且对于血压的控制需要长期进行坚持,而目前的有些中药需要患者在服用前进行煎煮,造成不便,或是口感不佳,导致患者无法坚持。而中药代茶饮,指用中草药与茶叶配用,代茶冲泡或以中草药(单味或复方),然后像茶一样饮用。中药代茶饮为我国的传统剂型,是在中医理、法、方、药理论原则指导下,依据辩证或辩证与辩病相结合对病情的判断,为防治疾病、病后调理或仅为养生保健而组方选药与茶叶合制而成的剂型。因此,有必要开发出一种能够满足患者长期饮用,对血压进行有效控制的中药代茶饮。
发明内容
因此,基于以上背景,本发明对现有技术改进,提供一种降压中药代茶饮,根据中医辨证合理组方,便于患者长期饮用,以满足对长期对血压进行改善及其控制。
本发明提供的技术方案为:
一种降压中药代茶饮,按重量计,其由罗布麻3-5份、山楂2-5份、山萸肉2-5份、三七花1-2份、枸杞子2-4份、车前子1-2份、天麻2-5份制成。
优选地,按重量计,其由罗布麻3份、山楂2份、山萸肉2份、三七花1份、枸杞子2份、车前子1份、天麻2份制成。
优选地,按重量计,其由罗布麻5份、山楂5份、山萸肉5份、三七花2份、枸杞子4份、车前子2份、天麻5份制成。
优选地,按重量计,其由罗布麻4份、山楂3份、山萸肉4份、三七花2份、枸杞子3份、车前子2份、天麻4份制成。
进一步地,其制备包括如下步骤:
S1:按比例取料;
S2:天麻和山楂分别用中药粉碎机打碎成粗末,过筛去细粉;
S3:将天麻、山楂及其其他原料进行装袋,即可。
优选地,步骤S3装袋用袋子采用食品级玉米纤维材料制成。
本发明中罗布麻性微寒,味苦甘,清火,降压,强心,利尿,平肝安神;现代药理研究表明罗布麻叶含有大量黄酮,黄酮化学结构系槲皮素和异槲皮素甙,其药理作用有降血压、降血脂、增加冠状动脉流量,对高血压、高血脂、有较好的疗效,尤其对头晕症状、改善睡眠质量有明显效果,同时具有增强免疫、消除抑郁、解酒护肝、通便利尿等功效。
三七花性凉,味甘,清热,平肝,降压;现代药理研究表明三七花是三七全株中三七皂苷含量最高的部分,三七皂苷具有降血脂、降血压、提高心肌供氧能力、增强机体免疫功能。另外三七花总皂甙对中枢神经系统呈抑制作用,表现为镇静、安神功效,对高血压伴有失眠焦虑的很好的疗效;枸杞多糖可降低大鼠血压(收缩压和舒张压均见效果);降低血浆及血管中丙二醛、内皮素含量,增加降钙素基因相关肽的释放,防止高血压形成。
山楂性微温,味酸甘,消食健胃,行气散瘀,化浊降脂。用于肉食积滞,胃脘胀满,泄痢腹痛,瘀血经闭,产后瘀阻,心腹刺痛,胸痹心痛,疝气疼痛,高脂血症。焦山楂消食导滞作用增强。用于肉食积滞,泻痢不爽。
山萸肉性微温,味酸,补益肝肾,收涩固脱,现代药理研究表明其还具有抗氧化、降血脂、降糖等作用,对糖尿病、肾病级糖尿病及其血管并发症具有改善作用。
枸杞子性平,味甘,润肺,明目,补肝肾,清热,止渴,补虚益精。用于虚劳精亏,腰膝酸痛,眩晕耳鸣,阳萎遗精,内热消渴,血虚萎黄,目昏不明。
车前子性寒,味甘,清热利尿通淋,渗湿止泻,明目,祛痰,能增加对水分、钠盐、尿酸、尿素的排泄,对舒张压的降低很有疗效。
天麻性平,味甘,息风止痉,平抑肝阳,祛风通络。
本发明辨证分析,组方中罗布麻、三七花皆具有清热降火、平肝熄风之功效,二药为叶为花,质地轻扬,主治上焦引起头痛、眩晕、失眠、焦虑、抑郁;山楂入脾、胃、肝经,消食积,散瘀血,其味酸甘,微温,味道醇厚可消中焦痰浊瘀堵,恢复气机升降出入;车前子甘寒利水泻浊,助山楂将水饮痰浊从下焦引出,同时清肝明目;枸杞、山萸肉滋补肝肾,可治腰酸腿软乏力视物模糊,另外益气养血,培元固本,以收濡养诸脏清窍之功;天麻润而不燥,主入肝经,长于平肝息风,凡肝风内动、头目眩晕之症,不论虚实,均为要药。
全方寒热并用,消补兼施,共奏清热平肝、化痰降浊、培元固本之功,能调和气血,平衡阴阳,从不同层面具有多靶点降压作用,兼具调节血脂、血糖控制功效,且可改善冠脉血流、提高心肌细胞缺氧耐受性、中枢神经系统调节、体液代谢、心脑肾等器官的灌注等病症。
并且本发明注重口感的选择配伍,使得患者能够理解并接受,利于患者长期饮用。
本发明选择药物配伍,选择药性平和药物进行组方,无副作用。
具体实施方式
现将详细地提供本发明实施方式的参考,其一个或多个实例描述于下文。提供每一实例作为解释而非限制本发明。实际上,对本领域技术人员而言,显而易见的是,可以对本发明进行多种修改和变化而不背离本发明的范围或精神。例如,作为一个实施方式的部分而说明或描述的特征可以用于另一实施方式中,来产生更进一步的实施方式。
因此,旨在本发明覆盖落入所附权利要求的范围及其等同范围中的此类修改和变化。本发明的其它对象、特征和方面公开于以下详细描述中或从中是显而易见的。本领域普通技术人员应理解本讨论仅是示例性实施方式的描述,而非意在限制本发明更广阔的方面。下面结合实施例对本发明做进一步说明。
实施例1:一种降压中药代茶饮,按重量计,其由罗布麻3份、山楂2份、山萸肉2份、三七花1份、枸杞子2份、车前子1份、天麻2份制成。
实施例2:一种降压中药代茶饮,按重量计,其由罗布麻5份、山楂5份、山萸肉5份、三七花2份、枸杞子4份、车前子2份、天麻5份制成。
实施例3:一种降压中药代茶饮,按重量计,其由罗布麻4份、山楂3份、山萸肉4份、三七花2份、枸杞子3份、车前子2份、天麻4份制成。
其制备包括如下步骤:
S1:按比例取料;
S2:天麻和山楂分别用中药粉碎机打碎成粗末,过筛去细粉;
S3:将天麻、山楂及其其他原料进行装袋,即可。
步骤S3装袋用袋子采用食品级玉米纤维材料制成。
使用时,每次一袋,用开水 500ml浸泡半小时后即可食用,每袋可以泡2-3次,每天2袋;
实施例4:典型案例
案例1:周某,女,40岁,经常性的感觉到胸闷不适应,并伴有阵发性眩晕,就诊时,血压检测值为155/93,持续性服用实施例2的中药代茶饮15天后,连续三天检测血压,均正常。
案例2:李某,男,44岁,经常性饮酒,血压检测经常超出正常范围,且经常性的伴有头痛、眩晕,就诊时,血压检测值为161/88,持续性服用实施例2的中药代茶饮10天后,连续三天检测血压,均正常。
案例3:周某,男,71岁,常年患有高血压,伴有眩晕、耳鸣、多梦等症状,就诊时,血压检测值为165/100,持续服用实施例2的中药代茶一个月后,连续三天检测血压,血压分别为140/90、140/89、142/90。
以上所述实施例的各技术特征可以进行任意的组合,为使描述简洁,未对上述实施例中的各个技术特征所有可能的组合都进行描述,然而,只要这些技术特征的组合不存在矛盾,都应当认为是本说明书记载的范围。
Claims (6)
1.一种降压中药代茶饮,其特征在于,
按重量计,其由罗布麻3-5份、山楂2-5份、山萸肉2-5份、三七花1-2份、枸杞子2-4份、车前子1-2份、天麻2-5份制成。
2.根据权利要求1所述的一种降压中药代茶饮,其特征在于,按重量计,其由罗布麻3份、山楂2份、山萸肉2份、三七花1份、枸杞子2份、车前子1份、天麻2份制成。
3.根据权利要求1所述的一种降压中药代茶饮,其特征在于,按重量计,其由罗布麻5份、山楂5份、山萸肉5份、三七花2份、枸杞子4份、车前子2份、天麻5份制成。
4.根据权利要求1所述的一种降压中药代茶饮,其特征在于,按重量计,其由罗布麻4份、山楂3份、山萸肉4份、三七花2份、枸杞子3份、车前子2份、天麻4份制成。
5.根据权利要求1至4任一项所述的一种降压中药代茶饮,其特征在于,其制备包括如下步骤:
S1:按比例取料;
S2:天麻片和山楂分别用中药粉碎机打碎成粗末,过筛去细粉;
S3:将天麻片、山楂及其其他原料进行装袋,即可。
6.根据权利要求5所述的一种降压中药代茶饮,其特征在于,步骤S3装袋用袋子采用食品级玉米纤维材料制成。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211349577.4A CN115887584B (zh) | 2022-10-31 | 2022-10-31 | 一种降压中药代茶饮 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211349577.4A CN115887584B (zh) | 2022-10-31 | 2022-10-31 | 一种降压中药代茶饮 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115887584A CN115887584A (zh) | 2023-04-04 |
CN115887584B true CN115887584B (zh) | 2024-04-12 |
Family
ID=86470205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211349577.4A Active CN115887584B (zh) | 2022-10-31 | 2022-10-31 | 一种降压中药代茶饮 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115887584B (zh) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1895557A (zh) * | 2006-06-28 | 2007-01-17 | 陈志忠 | 一种治疗高血压、高血脂、高血糖的中草药剂 |
CN101032602A (zh) * | 2006-03-10 | 2007-09-12 | 陈维森 | 天香降压胶囊 |
CN101099828A (zh) * | 2007-06-27 | 2008-01-09 | 陕西盘龙制药集团有限公司 | 一种用于降血压及改善睡眠的软胶囊 |
CN102356789A (zh) * | 2011-09-22 | 2012-02-22 | 黄馨莹 | 一种降压保健茶 |
CN102614390A (zh) * | 2012-05-01 | 2012-08-01 | 马守云 | 一种治疗高血压病的药物 |
CN104642663A (zh) * | 2015-02-01 | 2015-05-27 | 顾明健 | 一种罗布麻降压茶 |
CN107467315A (zh) * | 2017-09-28 | 2017-12-15 | 山西中医药大学 | 一种降压降脂茶及其制备方法 |
CN109588706A (zh) * | 2018-12-20 | 2019-04-09 | 韦德举 | 一种调节三高的富硒山楂枸杞营养食品及其制备方法 |
-
2022
- 2022-10-31 CN CN202211349577.4A patent/CN115887584B/zh active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101032602A (zh) * | 2006-03-10 | 2007-09-12 | 陈维森 | 天香降压胶囊 |
CN1895557A (zh) * | 2006-06-28 | 2007-01-17 | 陈志忠 | 一种治疗高血压、高血脂、高血糖的中草药剂 |
CN101099828A (zh) * | 2007-06-27 | 2008-01-09 | 陕西盘龙制药集团有限公司 | 一种用于降血压及改善睡眠的软胶囊 |
CN102356789A (zh) * | 2011-09-22 | 2012-02-22 | 黄馨莹 | 一种降压保健茶 |
CN102614390A (zh) * | 2012-05-01 | 2012-08-01 | 马守云 | 一种治疗高血压病的药物 |
CN104642663A (zh) * | 2015-02-01 | 2015-05-27 | 顾明健 | 一种罗布麻降压茶 |
CN107467315A (zh) * | 2017-09-28 | 2017-12-15 | 山西中医药大学 | 一种降压降脂茶及其制备方法 |
CN109588706A (zh) * | 2018-12-20 | 2019-04-09 | 韦德举 | 一种调节三高的富硒山楂枸杞营养食品及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN115887584A (zh) | 2023-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102068707B (zh) | 一种b超使用的中药助影剂及其制备方法 | |
CN103520621B (zh) | 一种治疗老年性白内障的中药组合物及其制备方法 | |
CN102578329A (zh) | 一种保健茶 | |
CN109847027A (zh) | 一种固本化痰降脂中药组合物及其制剂的制备工艺 | |
CN115887584B (zh) | 一种降压中药代茶饮 | |
CN101869164B (zh) | 一种零余子养颜茶 | |
CN112970992A (zh) | 一种适合糖尿病人的固体饮料及制作方法 | |
CN102512607A (zh) | 降血压保健品 | |
CN111905087A (zh) | 一种解酒保肝养生保健品组方 | |
CN106177484A (zh) | 一种清热利湿治疗泌尿结石的药茶及制备加工方法 | |
CN111870630A (zh) | 一种用于增加抵抗力和免疫力的药物配方及制备工艺 | |
CN109010518A (zh) | 降压茶及其制备方法和应用方法 | |
CN106615333A (zh) | 一种园金柑健脾理气茶及其制备方法 | |
CN105031563A (zh) | 化淤酒 | |
CN104886703A (zh) | 一种包含人工培植虫草黄芪枸杞子的植物饮料及配方和制造方法 | |
CN106165749A (zh) | 一种治疗气血虚弱贫血药茶及制备加工方法 | |
CN106165745A (zh) | 一种益气滋肾养阴治疗血小板减少症的药茶及制备加工方法 | |
CN106173037A (zh) | 一种固脾肾化湿浊治疗前列腺炎的药茶及制备加工方法 | |
CN105233093A (zh) | 一种治疗胃下垂的中药片剂 | |
CN109010519A (zh) | 降压茶及其制备方法和应用方法 | |
CN105249089A (zh) | 一种土元薏苡仁乳饮料及其制备方法 | |
CN114796096A (zh) | 一种用于安神助眠的药茶及其制备方法 | |
CN109170893A (zh) | 用于高血压症的食疗营养素固体饮料及其制备方法 | |
CN114794476A (zh) | 一种具有补益安神功能的组合物及其制备方法 | |
CN109136044A (zh) | 一种养颜保健酒及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |